Trade AstraZeneca ^AZN

Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials

Oxbow Advisors LLC Boosts Stock Position in AstraZeneca PLC $AZN

Jennison Associates LLC Sells 8,481,701 Shares of AstraZeneca PLC $AZN

AstraZeneca (LON:AZN) Shares Cross Above Two Hundred Day Moving Average - What's Next?

AstraZeneca PLC $AZN Shares Bought by Oxbow Advisors LLC - Daily Political

iA Global Asset Management Inc. Increases Holdings in AstraZeneca PLC $AZN - Stock Observer

Is Daiichi Sankyo (TSE:4568) Turning ENHERTU's China Approval Into a Durable Oncology Moat?

AstraZeneca's Tagrisso® and Calquence® Among First Oncology Treatments Granted Accelerated Access Through Ontario's FAST Program

Sun Pharmaceuticals Industries Ltd Futures Share Price & Chart Today | IIFL Capital

AstraZeneca to Fight Final $1.3 Million Indian Tax Assessment

Migdal Insurance & Financial Holdings Ltd. Acquires Shares of 194,000 AstraZeneca PLC $AZN - Markets Daily

Nature Medicine Commission on dialysis policy in low- and middle-income countries

Danish pension fund sells off US debt amid Trump-Greenland row

AZN: Oncology Pipeline And 2030 Sales Ambition Will Support Re Rating

AstraZeneca Moves to NYSE: Delisting from Nasdaq in Favor of Direct Listing, ETPharma

Dynasty Wealth Management LLC Invests $3.27 Million in AstraZeneca PLC $AZN

AstraZeneca PLC (AZN) Gains After Successful Saphnelo Trial

The Bull Case For Illumina (ILMN) Could Change Following Its Billion Cell Atlas Pharma Alliance

From wildfires to inhalers: The hidden environmental cost of respiratory care and how tech may help | Euronews

Astrazeneca expands China cell therapy footprint with Abelzeta CAR T | BioWorld

AstraZeneca Expects Ordinary Shares, Debt Securities To Commence Trading On NYSE From Feb. 2

Chemosensory response to Pt-based chemotherapeutics via bitter taste receptors in vitro reveals a new mechanism for bitter taste disorders

EMA validates Type II Variation MAA for AstraZeneca, Daiichi's Enhertu | Markets Insider

AstraZeneca (AZN) - Investment Analysts' Recent Ratings Updates - Daily Political

Top Medical Stocks To Consider - January 19th - Stock Observer

ENHERTU® Plus Pertuzumab Type II Variation Application Validated in the EU as First-Line Treatment of Patients with HER2 Positive Metastatic Breast Cancer

Best Medical Stocks To Research - January 18th - Markets Daily

AstraZeneca PLC $AZN Shares Sold by QRG Capital Management Inc.

AstraZeneca PLC (NASDAQ:AZN) Short Interest Update - Daily Political

AstraZeneca PLC $AZN Shares Sold by Sumitomo Mitsui Trust Group Inc. - Stock Observer

Top Medical Stocks Worth Watching - January 17th - Markets Daily

Merck's Oncology Deals And Genomics Push Might Change The Case For Investing In Merck (MRK)

Klein Pavlis & Peasley Financial Inc. Makes New $1.08 Million Investment in AstraZeneca PLC $AZN - Stock Observer

AstraZeneca (NASDAQ:AZN) Downgraded to "Buy" Rating by Wall Street Zen

Shore Capital Sticks to Its Buy Rating for AstraZeneca (AZN) | Markets Insider

12 Best Future Stocks to Buy For the Long Term

Pharmaceutical Stocks To Keep An Eye On - January 16th - Markets Daily

Deutsche Bank Aktiengesellschaft Issues Positive Forecast for AstraZeneca (LON:AZN) Stock Price - Markets Daily

AstraZeneca (LON:AZN) Stock Price Expected to Rise, Deutsche Bank Aktiengesellschaft Analyst Says

AstraZeneca (LON:AZN) Receives Buy Rating from Shore Capital - Daily Political

Barclays Sticks to Its Buy Rating for AstraZeneca (AZN) | Markets Insider

Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland

What Makes AstraZeneca (AZN) a Strong Growing Company?

AstraZeneca Spotlights 2025 Growth, 2026 Launch Wave and $80B 2030 Goal at JPM Conference

Rep. Julia Letlow Buys AstraZeneca PLC (NASDAQ:AZN) Shares

AstraZeneca (NASDAQ:AZN) Stock Acquired Rep. Gilbert Ray Cisneros, Jr.

TR/CC CRB Index (TRCCRB) - Investing.com Canada

Lynx Analytics Introduces Lumen, an Agentic AI Framework to Improve Decision-Making in Life Sciences | Morningstar

Manning & Napier Advisors LLC Sells 390,342 Shares of AstraZeneca PLC $AZN - Stock Observer

Diagnostic whole transcriptome sequencing in a series of 1233 FFPE solid tumor samples

Promising Pharmaceutical Stocks To Add to Your Watchlist - January 13th - Markets Daily

Illumina launches dataset to speed up AI-powered drug discovery - The Economic Times

AstraZeneca to acquire Modella AI to speed oncology drug research

ERN GENTURIS guideline on counselling on reproductive options for individuals with a cancer predisposition syndrome (including genturis)

Linavonkibart and pembrolizumab in immune checkpoint blockade-resistant advanced solid tumors: a phase 1 trial

Is Walmart now a tech company? Stock surges after AI moves, Nasdaq-100 inclusion. | Morningstar

SG Americas Securities LLC Grows Stock Position in AstraZeneca PLC $AZN

Assessing Walmart (WMT) Valuation As Nasdaq 100 Entry And Tech Push Draw Fresh Attention

Artificial intelligence agents in cancer research and oncology

AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit

Nasdaq Adds Walmart To Nasdaq-100, Drops AstraZeneca In Index Reshuffle | Crowdfund Insider

Nasdaq-100 reshuffle: Walmart set to join US stock market index; to replace AstraZeneca from January 20 - The Times of India

Berenberg Bank Remains Bullish on AstraZeneca PLC (AZN) - Here's Why

Walmart to join Nasdaq 100 from January 20 as AstraZeneca exits the index

Walmart Joins Nasdaq-100, Replacing AstraZeneca: Key Corporate Shift, ETRetail

Walmart to join Nasdaq 100 on Jan 20 as AstraZeneca exits - The Business Times

Walmart to replace AstraZeneca on Nasdaq-100 Index on January 20

Oak Family Advisors LLC Sells 23,242 Shares of AstraZeneca PLC $AZN

European Drug Pricing Tensions Rise After Trump's U.S. Price Cuts, ETPharma

Cellectis Announces 2026 Strategy and Catalysts

Cellectis annonce sa stratégie et ses jalons attendus en 2026

AstraZeneca's (AZN) Overweight Rating Reaffirmed at JPMorgan Chase & Co. - Markets Daily

JPMorgan Chase & Co. Reiterates Overweight Rating for AstraZeneca (LON:AZN)

Park Avenue Securities LLC Boosts Stock Position in AstraZeneca PLC $AZN

Vaughan Nelson Investment Management L.P. Acquires Shares of 23,726 AstraZeneca PLC $AZN - Markets Daily

Vaughan Nelson Investment Management L.P. Makes New Investment in AstraZeneca PLC $AZN - Daily Political

Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 35% One-Year Rally?

Clinical outcomes with perioperative nivolumab by nodal status in patients with stage III resectable NSCLC: phase 3 CheckMate 77T exploratory analysis

AstraZeneca (LON:AZN) Sets New 52-Week High - Still a Buy?

AstraZeneca (LON:AZN) Stock Crosses Above 200-Day Moving Average - Should You Sell?

European Shares Seen Mostly Higher In Cautious Trade

Alnuctamab, a bivalent B-cell maturation antigen-targeting T cell engager for patients with relapsed or refractory multiple myeloma: results from a phase 1, first-in-human study

Quality quartet sprinkle more gold dust on glittering Awards sponsor line-up

Spatially resolved integrative analysis of transcriptomic and metabolomic changes in tissue injury studies

CD19 CAR-T cells for treatment-refractory autoimmune diseases: the phase 1/2 CASTLE basket trial

Molecular and functional characterization of the B-cell receptor in chronic lymphocytic leukemia-like monoclonal B-cell lymphocytosis

AstraZeneca (NASDAQ:AZN) Sets New 1-Year High - What's Next?